Similarly, (xvii) a brain-targeted CRISPR/Cas9-based nanomedicine was developed by fabricating angiopep-2-decorated, guanidinium- and fluorine-functionalized polymeric nanoparticles that loaded Cas9/gRNA RNP for the treatment of GBM. Here, RNPC3 is linked to glioblastoma.